Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Neuroimage ; 288: 120538, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38342189

ABSTRACT

In daily life, faces are often memorized within contexts involving interpersonal interactions. However, little is known about whether interpersonal interaction-related contexts influence face memory. The present study aimed to understand this question by investigating how social comparison-related context affects face encoding and recognition. To address this issue, 40 participants were informed that they and another player each played a monetary game and were then presented with both of their outcomes (either monetary gain or loss). Subsequently, participants were shown the face of the player whom they were just paired with. After all the faces had been encoded, participants were asked to perform a sudden old/new recognition task involving these faces. The results showed that, during the encoding phase, another player's monetary gain, compared to loss, resulted in more negative responses in the N170 and early posterior negativity (EPN)/N250 to relevant players' faces when participants encountered monetary loss and a smaller late positive potential (LPP) response irrespective of self-related outcomes. In the subsequent recognition phase, preceding another player's monetary gain as compared to loss led to better recognition performance and stronger EPN/N250 and LPP responses to the faces of relevant players when participants had lost some amount of money. These findings suggest that the social comparison-related context, particularly self-disadvantageous outcomes in the context, influences the memory of comparators' faces.


Subject(s)
Electroencephalography , Facial Recognition , Humans , Evoked Potentials/physiology , Recognition, Psychology/physiology , Interpersonal Relations , Social Environment , Facial Recognition/physiology
2.
Psychophysiology ; 61(4): e14477, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37888488

ABSTRACT

In a complicated social context, outcome evaluation involves not only oneself but also others in relation to the self (i.e., social comparison). Previous event-related potential (ERP) studies have investigated the processing of social comparison-related outcomes when one's interests are independent of the interests of others (i.e., noncompetition circumstances). However, it is unclear how social comparison-related outcomes are processed in the brain when there are conflicts of interest between oneself and others (i.e., competition circumstances). To address this issue, participants in the current study were asked to perform an attentional task with several peers and were subsequently presented with self-related outcomes (i.e., the performance difference between the current trial and several preceding trials) and social comparison-related outcomes (i.e., the performance difference between oneself and their peer). Importantly, rewards and punishments were based on social comparison-related outcomes in the competition condition and on self-related outcomes in the noncompetition condition. ERP results revealed that in the competition condition, positive outcomes involving social comparison elicited a greater P300 response than negative outcomes, whereas this effect was not observed in the noncompetition condition. Additionally, there was generally a larger late positive potential (LPP) response to negative outcomes involving social comparison than to positive outcomes only when one obtained a self-related positive outcome in the competition condition. These findings suggest that competition might strengthen outcome processing involving social comparison at late time ranges relying on self-related outcomes to some extent.


Subject(s)
Electroencephalography , Social Comparison , Humans , Evoked Potentials/physiology , Brain/physiology , Social Environment
3.
BMC Geriatr ; 23(1): 636, 2023 10 09.
Article in English | MEDLINE | ID: mdl-37814237

ABSTRACT

This study investigated the effects of Tai Chi exercise on subjective well-being in the aged. The participants were randomly assigned to an experimental group or a control group. The experimental group received 12-week Tai Chi exercise while the control group maintain their original living habits. The participants' subjective well-being, physical fitness, self-control, and executive function were measured at baseline and after 12 weeks of Tai Chi exercise. Results: (1) Tai Chi exercise can positively affect the subjective well-being of the aged (F(1,78) = 37.699, p < 0.001); (2) Tai Chi exercise could affect the subjective well-being in the aged through the independent intermediary of physical fitness (95% CI=[0.115, 0.485]) and self-control (95% CI=[0.109, 0.433]); (3) Tai Chi exercise could indirectly affect the subjective well-being in the aged through the chain mediation of executive function and self-control (95% CI=[0.009, 0.104]). This study provides valuable insights into the potential benefits of Tai Chi exercise for subjective well-being in the aged.


Subject(s)
Tai Ji , Humans , Physical Fitness , Exercise , Cognition , Executive Function
4.
Clin Transl Oncol ; 25(12): 3527-3540, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37249759

ABSTRACT

BACKGROUND: Although aberrant expression of CDGSH iron sulfur domain 2 (CISD2) contributes to the tumorigenesis and progression of numerous human cancers, the biological function of CISD2 and its specific prognostic value in lung squamous cell carcinoma (LUSC) have yet to be comprehensively explored. The current study aimed to elucidate the role of CISD2 in LUSC as well as the underlying molecular mechanisms. METHODS: Immunohistochemistry was conducted to detect the protein expression of CISD2 and analyze whether high expression of CISD2 affects the overall survival (OS) of LUSC patients. Cell proliferation, colony formation, wound healing and Transwell invasion assays were performed to clarify whether CISD2 contributes to LUSC cell proliferation and disease progression. Quantitative real-time reverse transcription-PCR and western blot assays were used to detect the levels of transcription factors and key epithelial-mesenchymal transition (EMT)-related markers in LUSC cells after CISD2 knockdown and overexpression to determine whether CISD2 regulates transforming growth factor-beta (TGF-ß)-induced EMT in LUSC. RESULTS: Immunohistochemistry of human tissue microarrays containing 90 pairs of adjacent and cancerous tissues revealed that CISD2 is considerably overexpressed in LUSC and strongly linked to poor OS. Functional experiments suggested that silencing endogenous CISD2 inhibited the growth, colony formation, migration, and invasion of H2170 and H226 cell lines. Exogenous overexpression of CISD2 facilitated these phenotypes in SK-MES-1 and H2170 cells. Furthermore, CISD2 promoted EMT progression by increasing the expression of mesenchymal markers (N-cadherin, vimentin, Snail, and Slug) as well as SMAD2/3 and reducing the expression of the epithelial marker E-cadherin. Mechanistically, our studies provide the first evidence that CISD2 can promote EMT by enhancing TGF-ß1-induced Smad2/3 expression in LUSC cells. CONCLUSION: In conclusion, our research illustrates that CISD2 is highly expressed in LUSC and may facilitate LUSC proliferation and metastasis. Thus, CISD2 may serve as an independent prognostic marker and possible treatment target for LUSC.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Carcinoma, Squamous Cell , Lung Neoplasms , Humans , Cell Line, Tumor , Cell Movement , Epithelial-Mesenchymal Transition/physiology , Lung , Lung Neoplasms/pathology , Signal Transduction , Transforming Growth Factor beta1/pharmacology , Transforming Growth Factor beta1/metabolism
5.
Brain Behav ; 13(7): e3065, 2023 07.
Article in English | MEDLINE | ID: mdl-37183558

ABSTRACT

INTRODUCTION: Labeling the emotional aspect of self-unrelated stimuli (i.e., affect labeling) is a crucial strategy for implicit emotion regulation. However, it is uncertain whether affect labeling influences event-related potential (ERP) responses (e.g., the late positive potential, LPP) to negative stimuli in comparison with control conditions in which attention is shifted to the emotional content of the stimuli (e.g., affect matching). Additionally, it is unknown whether affect labeling has a lasting effect on the processing of negative stimuli. METHODS: Participants were required to label the emotion (negative or neutral) of target pictures with two words, to match the emotion with alternative pictures or to merely view the target pictures. Target pictures were presented again immediately after the regulation task. After all the target pictures had been labeled, matched and viewed, the pictures were re-exposed for the third time. RESULTS: The results showed that negative pictures elicited larger late LPP responses during the affect labeling task than during other tasks. However, the LPP responses were smaller for negative pictures in the affect labeling condition than in the other conditions when target pictures were re-exposed immediately after the task. When target pictures were re-presented again long after the regulation tasks, the LPP responses were smaller for negative stimuli with a history of affect labeling than viewing, whereas this effect did not differ between the affect labeling and matching conditions. CONCLUSION: The current findings suggest that affect labeling has current effects and, to some extent, has lasting effects on negative stimulus processing.


Subject(s)
Electroencephalography , Emotions , Humans , Electroencephalography/methods , Photic Stimulation , Emotions/physiology , Evoked Potentials/physiology , Attention/physiology
6.
Mol Immunol ; 153: 135-145, 2023 01.
Article in English | MEDLINE | ID: mdl-36495818

ABSTRACT

Chronic inflammation might lead to many malignancies, and inadequate resolution could play a crucial role in tumor invasion, progression and metastases. Afatinib is a second-generation tyrosine kinase inhibitor targeting epidermal growth factor receptor in non-small cell lung cancer. Few studies showed the correlation of afatinib and the innate immune system especially macrophage. Our study showed that afatinib could block the activation of NLRP3 inflammasome in a dose-dependent manner in macrophage, and that afatinib could prevent the assembly of NLRP3 inflammasome. Besides, afatinib could inhibit NLRP3 inflammasome activation independent of EGFR signaling. Moreover, afatinib was able to alleviate the LPS-induced sepsis in vivo. These investigations provide significant experimental evidence in afatinib as therapeutic drug for non-small cell lung cancer or other tumors and NLRP3-related diseases, and explore new target for afatinib in macrophage.


Subject(s)
Afatinib , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Humans , Afatinib/pharmacology , Carcinoma, Non-Small-Cell Lung/metabolism , ErbB Receptors , Inflammasomes/metabolism , Lung Neoplasms/pathology , Macrophages/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , /pharmacology
7.
Int J Psychophysiol ; 183: 32-40, 2023 01.
Article in English | MEDLINE | ID: mdl-36375630

ABSTRACT

Previous studies have suggested that emotional primes, presented as visual stimuli, influence face memory (e.g., encoding and recognition). However, due to stimulus-associated issues, whether emotional primes affect face encoding when the priming stimuli are presented in an auditory modality remains controversial. Moreover, no studies have investigated whether the effects of emotional auditory primes are maintained in later stages of face memory, such as face recognition. To address these issues, participants in the present study were asked to memorize angry and neutral faces. The faces were presented after a simple nonlinguistic interjection expressed with angry or neutral prosodies. Subsequently, participants completed an old/new recognition task in which only faces were presented. Event-related potential (ERP) results showed that during the encoding phase, all faces preceded by an angry vocal expression elicited larger N170 responses than faces preceded by a neutral vocal expression. Angry vocal expression also enhanced the late positive potential (LPP) responses specifically to angry faces. In the subsequent recognition phase, preceding angry vocal primes reduced early LPP responses to both angry and neutral faces and late LPP responses specifically to neutral faces. These findings suggest that the negative emotion of auditory primes influenced face encoding and recognition.


Subject(s)
Electroencephalography , Evoked Potentials , Humans , Reaction Time/physiology , Evoked Potentials/physiology , Emotions/physiology , Recognition, Psychology/physiology , Facial Expression
8.
Psychol Res ; 87(5): 1590-1606, 2023 Jul.
Article in English | MEDLINE | ID: mdl-36307594

ABSTRACT

Behavioral and event-related potential (ERP) studies have shown that the expressions of a face displayed in the encoding phase (encoded facial expressions) influences identity recognition of this face in a later recognition phase. As facial expressions displayed in the recognition phase (recognized facial expressions) might also influence facial identity recognition, the current study investigated whether the effect of encoded facial expressions on facial identity recognition changed depending on recognized facial expressions. Therefore, participants were asked to learn facial identities displaying angry, happy or neutral expressions during the encoding phase. In the subsequent recognition phase, participants were presented with the learned identities and several novel identities and asked to judge whether the prompted identities had been learned. Each identity displayed angry, happy and neutral expressions. The results showed that d' scores were smaller for happy-recognized identities (i.e., learned identities displaying happy expressions during the recognition phase) in the angry-encoded (i.e., learned identities that had displayed angry expressions during the preceding encoding phase) condition than in the neutral-encoded condition and for neutral-recognized identities in the angry-encoded condition than in the happy-encoded condition. ERP results showed that angry-encoded identities elicited less negative responses in the P200 and early posterior negativity (EPN)/N250 components and less positive responses in the late positive potential (LPP) component than happy-encoded identities. For neutral-recognized identities, LPP responses were reduced in the angry-encoded condition compared with those in the neutral-encoded condition. These findings might contribute to understanding the influence of previous and current facial expressions on facial identity recognition.


Subject(s)
Facial Expression , Facial Recognition , Humans , Facial Recognition/physiology , Evoked Potentials/physiology , Happiness , Anger , Emotions/physiology
9.
Front Psychol ; 12: 769826, 2021.
Article in English | MEDLINE | ID: mdl-34966330

ABSTRACT

Previous studies have investigated whether envy, particularly malicious envy, increases feelings of schadenfreude and whether this effect is evident in both gain and loss frames. However, as a social-comparison-based emotion, schadenfreude was not investigated through social comparisons in these previous studies. Thus, the present study aimed to investigate whether malicious envy influences schadenfreude when schadenfreude is elicited in the context of precise and ambiguous social comparisons. To address this issue, participants in the present study were asked to play a monetary game with several other players. In the experimental condition, participants gained less or lost more than the other player; in the control condition, both the participants and the player gained little or lost much. Subsequently, the participants observed that the player encountered a misfortune, that is, gained less or lost more money than the participant. The results showed that when participants knew the exact amount of monetary gained and lost by themselves and the other player (i.e., precise social comparisons), malicious envy increased feelings of schadenfreude only in the loss frame rather than in the gain frame. More importantly, malicious envy turned out to reduce feelings of schadenfreude in both gain and loss frames, when participants did not know the exact amount (i.e., ambiguous social comparisons). The findings provide novel evidence that malicious envy does not always increase schadenfreude particularly when schadenfreude is elicited through social comparisons.

10.
Psychophysiology ; 58(12): e13938, 2021 12.
Article in English | MEDLINE | ID: mdl-34482549

ABSTRACT

Previous event-related potential (ERP) studies have suggested that self-related and non-self-related outcomes are processed simultaneously. However, the studies investigated situations in which individuals had sufficient attentional/cognitive resources to process both of the outcomes. It is unknown whether self-related and non-self-unrelated outcomes could still be processed simultaneously when resources are limited. To address this issue, 32 female participants in the present study were asked to perform a working memory task. To manipulate the amount of available attentional/cognitive resources, participants were asked to memorize a letter in the low load condition and five letters in the high load condition. During letter consolidation, participants were informed that they and another player each performed a gambling task and were subsequently presented with both of the outcomes. ERP results showed that others' monetary loss elicited larger P200 and late positive potential amplitudes than others' monetary gain under a low working memory load, whereas a high load reduced these effects. However, working memory load did not influence the effect of self-outcome on ERP responses. Therefore, the findings suggest that the amount of available attentional/cognitive resources alters the evaluation of non-self-related but not self-related outcomes.


Subject(s)
Evoked Potentials/physiology , Memory, Short-Term/physiology , Psychomotor Performance/physiology , Reward , Social Perception , Adult , Ego , Electroencephalography , Female , Humans , Young Adult
11.
Front Hum Neurosci ; 15: 663055, 2021.
Article in English | MEDLINE | ID: mdl-34456693

ABSTRACT

Previous behavioral and neural studies have shown the effects of malicious envy on schadenfreude. However, it is unclear whether these effects are modulated by contextual frames (e.g., gain and loss frames). Thus, the present study aimed to investigate whether behavioral and event-related potential (ERP) effects of malicious envy on schadenfreude were different in gain and loss frames. To address this issue, the participants in the present study believed they were playing a monetary game with several other players. In the malicious envy condition, the participants won less money than the player in the gain frame and lost more money in the loss frame; in the control condition, both participants and the player gained little money in the gain frame and lost much in the loss frame. Subsequently, the participants were informed that the player encountered a misfortune, i.e., gained little in the gain frame and lost much in the loss frame. Results showed that malicious envy increased feelings of schadenfreude and ERP responses when the player encountered a misfortune. Moreover, increased ERP responses by malicious envy occurred at the feedback-related negativity (FRN), and early late positive potential (LPP) time ranges in the gain frame but at the late LPP time range in the loss frame. The findings might suggest that malicious envy affects schadenfreude and corresponding neural activity, whereas the neural effects occur at comparatively early time ranges in the gain frame but at a later time range in the loss frame.

12.
Front Oncol ; 11: 652193, 2021.
Article in English | MEDLINE | ID: mdl-34221970

ABSTRACT

BACKGROUND: Micropapillary adenocarcinoma is one of the most aggressive histologic subtypes of lung adenocarcinoma (LADC), and even a minor proportion of micropapillary component (MPC) within the LADC could contribute to poor prognosis. Comprehensive analysis of genetic and immunological features of LADC with different percentages of MPC would help better understand cancer biology of this LADC subtype and direct future treatments. METHODS: We performed next-generation sequencing (NGS) for a discovery cohort of 43 LADC patients whose tumors were micro-dissected to separate MPC and non-MPC lesions and a reference cohort of 113 LADC patients. MPC-enriched genetic alterations that were detected in the discovery cohort were then confirmed using a validation cohort of 183 LADC patients. Immunological staining was also conducted on the MPC-containing samples in the discovery cohort. RESULTS: Tumors with a higher percentage of MPC tended to harbor more tumor mutation burdens (TMBs) and chromosome instability (CIN). Some rare genetic events may serve as the genetic landscape to drive micropapillary tumor progression. Specifically, alterations in transcription termination factor 1 (TTF1), brain-specific angiogenesis inhibitor 3 (BAI3), mammalian target of rapamycin (MTOR), and cyclin-dependent kinase inhibitor 2A (CDKN2A) were cross-validated to be enriched in MPC-contained LADC. Additionally, tumors with a higher percentage of MPC were associated with a higher percentage of CD4+, CD8+, and PD-L1+ staining, and some genetic changes that were enriched in MPC, including MET amplification and MTOR mutation, were correlated with increased PD-L1 expression. CONCLUSION: We identified multiple novel MPC-enriched genetic changes that could help us understand the nature of this aggressive cancer subtype. High MPC tumors tended to have elevated levels of TMBs, T cell infiltration, and immunosuppression than low MPC tumors, implying the potential link between MPC content and sensitivity to immunotherapy.

13.
BMC Cancer ; 21(1): 511, 2021 May 07.
Article in English | MEDLINE | ID: mdl-33962566

ABSTRACT

BACKGROUND: Concurrent chemo-radiotherapy remains the standard treatment in unresectable stage III non-small-cell lung cancer (NSCLC) patients. Several studies have shown a potential value of concurrent epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) with thoracic radiotherapy in EGFR-mutated population, but a high risk of radiation pneumonitis raised a major concern. This study intends to explore the safety and efficacy of concurrent almonertinib, a new third-generation EGFR-TKI, with radiotherapy in locally advanced EGFR-mutated NSCLC patients. METHODS: Locally advanced NSCLC patients harboring sensitive EGFR mutation will be included in this study. A radiotherapy plan will be made for each patient before treatment, and the lung V20 will be calculated. Patients with lung V20 ≥ 28% were enrolled in induction group (arm A), which almonertinib was given for 2 months followed by concurrent radiotherapy; patients with lung V20 < 28% were enrolled in concurrent group (arm B), which almonertinib was given concurrent with thoracic radiotherapy. The primary endpoint is the incidence of grade ≥ 3 radiation pneumonitis within 6 months post-radiotherapy, and the secondary endpoints are local control rate, progression-free survival, and overall survival. DISCUSSION: The safety and efficacy of third-generation EGFR-TKI concurrent with thoracic radiotherapy in locally advanced EGFR-mutated NSCLC is still unknown. We propose to conduct this phase 2 study evaluating the safety especially the radiation pneumonitis within 6 months post-radiotherapy. This trial protocol has been approved by the Ethics committee of Hangzhou cancer hospital. The ethics number is HZCH-2020-030. TRIAL REGISTRATION: clinicaltrials.gov, NCT04636593 . Registered 19 November 2020 - Retrospectively registered.


Subject(s)
Acrylamides/therapeutic use , Carcinoma, Non-Small-Cell Lung/therapy , Chemoradiotherapy , Indoles/therapeutic use , Lung Neoplasms/therapy , Mutation , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , Humans , Lung Neoplasms/genetics , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Neoplasm Staging
14.
Scand J Psychol ; 62(3): 339-347, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33719048

ABSTRACT

We investigated whether experienced regret influences risky decision making in future dissimilar situations and whether this effect is affected by risky degree. Therefore, participants (N = 39 and 54 in Experiment 1 and 2, respectively) were asked to select one of the two options. In the experienced regret condition, the selected option was worse than the unselected option; in the control condition, the information about the unselected option was unknown to the participants. Subsequently, participants were required to either keep the selected option or to gamble. Additionally, Experiment 2 varied in risky degree of the gamble from low to high. Results showed that experienced regret enhanced possibilities of gamble under low risk (Experiment 1 and 2). Under high risk, however, the effect of experienced regret was reversed (Experiment 2). The findings might suggest that experienced regret affects risky decision making in future dissimilar situations dependently on risky degree.


Subject(s)
Emotions , Gambling , Decision Making , Humans , Risk-Taking
15.
Acta Pharmacol Sin ; 42(8): 1288-1297, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33159174

ABSTRACT

Recent evidence shows that the expression levels of histamine receptor H3 (Hrh3) are upregulated in several types of cancer. However, the role of Hrh3 in non-small cell lung cancer (NSCLC) has not been elucidated. In the present study, we showed that the expression levels of Hrh3 were significantly increased in NSCLC samples, and high levels of Hrh3 were associated with poor overall survival (OS) in NSCLC patients. In five human NSCLC cell lines tested, Hrh3 was significantly upregulated. In NSCLC cell lines H1975, H460, and A549, Hrh3 antagonist ciproxifan (CPX, 10-80 µM) exerted moderate and concentration-dependent inhibition on the cell growth and induced apoptosis, whereas its agonist RAMH (80 µM) reversed these effects. Furthermore, inhibition of Hrh3 by CPX or siRNA retarded the migration and invasion of NSCLC cells through inhibiting epithelial-mesenchymal transition (EMT) progression via reducing the phosphorylation of PI3K/Akt/mTOR and MEK/ERK signaling pathways. In nude mice bearing H1975 cell xenograft or A549 cell xenograft, administration of CPX (3 mg/kg every other day, intraperitoneal) significantly inhibited the tumor growth with increased E-cadherin and ZO-1 expression and decreased Fibronectin expression in tumor tissue. In conclusion, this study reveals that Hrh3 plays an important role in the growth and metastasis of NSCLC; it might be a potential therapeutic target against the lung cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Epithelial-Mesenchymal Transition/drug effects , Histamine Antagonists/pharmacology , Imidazoles/pharmacology , MAP Kinase Signaling System/drug effects , Receptors, Histamine H3/metabolism , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Carcinoma, Non-Small-Cell Lung/drug therapy , Cell Line, Tumor , Cell Proliferation/drug effects , Histamine Antagonists/therapeutic use , Humans , Imidazoles/therapeutic use , Lung Neoplasms/drug therapy , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , TOR Serine-Threonine Kinases/metabolism , Xenograft Model Antitumor Assays
16.
Zhongguo Fei Ai Za Zhi ; 23(11): 1007-1013, 2020 Nov 20.
Article in Chinese | MEDLINE | ID: mdl-33203200

ABSTRACT

Lung micropapillary adenocarcinoma is characterized by frequent metastasis, lymph node infiltration, high recurrence rate and low overall survival rate as a high-grade lung adenocarcinoma. Special oncogenic pathway is activated and immune microenvironment is established in this subtype of tumor. This article reviews the Pathological phenomena and molecular features of micropapillary adenocarcinoma studied in recent years, aiming to deepen the understanding of micropapillary lesions and lay the foundation for formulating specific treatment strategies.
.


Subject(s)
Lung Neoplasms/pathology , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism
17.
Front Hum Neurosci ; 14: 140, 2020.
Article in English | MEDLINE | ID: mdl-32351374

ABSTRACT

Individuals often predict consequences, particularly emotional consequences, according to emotional or non-emotional signals conveyed by environmental cues (i.e., emotional and non-emotional cues, respectively). Some of these cues signify the consequences with certainty (i.e., certain cues), whereas others do not (i.e., uncertain cues). Several event-related potential (ERP) studies regarding non-emotional cues have suggested that the effects of cue uncertainty on attention to emotional events occur in both perception and evaluation processes. However, due to the limitations of previous studies, it is unclear what the effects of cue uncertainty would be in an emotional cue condition. Moreover, it is uncertain whether the effects of cue uncertainty are affected by cue valence (i.e., emotional and non-emotional cues). To address these questions, we asked participants to view cues and then to view emotional (positive or negative) pictures. The cues either did or did not indicate the emotional content of the picture. In the emotional cue condition, happy and fearful faces were used as certain cues indicating upcoming positive and negative pictures, respectively, and neutral faces were used as uncertain cues. In the non-emotional cue condition, scrambled faces outlined in red and blue indicated upcoming positive and negative pictures, respectively, and scrambled faces outlined in green served as uncertain cues. The results showed that for negative pictures, ERP responses in a time range between 60 and 1,000 ms were shifted to a more negative direction in a certain condition than in the uncertain condition when the cues were emotional. However, the effect was the reverse for positive pictures. This effect of cue uncertainty was similar in the non-emotional cue-negative condition. In contrast, there was no effect of cue uncertainty in the non-emotional cue-positive condition. Therefore, the findings indicate that cue uncertainty modulates attention toward emotional events when the events are signified by emotional cues. The findings may also suggest that cue valence modulates the effects of cue uncertainty on attention to emotional events.

18.
J Thorac Dis ; 12(3): 883-892, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32274156

ABSTRACT

BACKGROUND: About 20-30% EGFR-mutant non-small lung cancer show intrinsic resistance to EGFR targeted therapies. Compared to T790M positive in acquired resistance patients, little is known about EGFR-TKI intrinsic resistance for T790M negative patients. METHODS: Thirty-one patients with advanced stage lung cancer, including 18 patients with intrinsic resistance (PFS <6 months) and 13 patients with acquired resistance (PFS >36 months) but are negative for plasma T790M were recruited in the study. Plasma cell free DNA was profiled by low coverage whole genome sequencing with median genome coverage of 1.86X by Illumina X10. Sequencing coverage across chromosomes was summarized by samtools, and normalized by segmentation analysis as provided by R package 'DNACopy'. RESULTS: The most frequent chromosomal changes were found on chr7, chr1 and chr8. Among them, chr7p gains were found in 12 (66.7%) intrinsic resistance and 4 (30.7%) acquired resistance patients. The gene EGFR was found located on the focal amplification peak of chr7p. The performance of 7p gain to predict intrinsic resistance reaches AUC =0.902. Similarly, focal amplifications were also found on chromosome 5, 16 and 22, where tumor related gene PCDHA@, ADAMTS18 and CRKL were located. Focal deletions were also found in chr1, 8, 10 and 16, where genes SFTPA1/2, DLC1, PTEN and CDH1 are located. CONCLUSIONS: The results suggest cell free DNA copy number might be a useful peripheral blood tumor biomarker for predicting intrinsic resistance of EGFR targeted therapy and prognosis.

19.
Acta Pharmacol Sin ; 41(6): 825-834, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32066885

ABSTRACT

Chalcomoracin (CMR) is a kind of Diels-Alder adduct extracted from the mulberry leaves. Recent studies showed that CMR has a broad spectrum of anticancer activities and induces paraptosis in breast cancer and prostate cancer cells. In this study, we investigated the effects of CMR against human non-small cell lung cancer cells and the underlying mechanisms. We found that CMR dose-dependently inhibited the proliferation of human lung cancer H460, A549 and PC-9 cells. Furthermore, exposure to low and median doses of CMR induced paraptosis but not apoptosis, which was presented as the formation of extensive cytoplasmic vacuolation with increased expression of endoplasmic reticulum stress markers, Bip and Chop, as well as activation of MAPK pathway in the lung cancer cells. Knockdown of Bip with siRNA not only reduced the cell-killing effect of CMR, but also decreased the percentage of cytoplasmic vacuoles in H460 cells. Moreover, CMR also increased the sensitivity of lung cancer cells to radiotherapy through enhanced endoplasmic reticulum stress. In lung cancer H460 cell xenograft nude mice, combined treatment of CMR and radiation caused greatly enhanced tumor growth inhibition with upregulation of endoplasmic reticulum stress proteins and activation of pErk in xenograft tumor tissue. These data demonstrate that the anticancer activity and radiosensitization effect of CMR result from inducing paraptosis, suggesting that CMR could be considered as a potential anticancer agent and radiation sensitizer in the future cancer therapeutics.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Benzofurans/pharmacology , Carcinoma, Non-Small-Cell Lung/therapy , Lung Neoplasms/therapy , A549 Cells , Animals , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Endoplasmic Reticulum Stress/drug effects , Female , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mice , Mice, Nude , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Neoplasms, Experimental/therapy , Tumor Cells, Cultured
20.
RSC Adv ; 10(44): 26460-26466, 2020 Jul 09.
Article in English | MEDLINE | ID: mdl-35519750

ABSTRACT

Sulfur-Doped graphene has attracted significant attention because of its potential uses in sensors, catalysts, and energy storage applications. In conventional approaches, the sulfur-doped graphene is fabricated with graphene oxide and sulfur-containing compounds through thermal annealing or hydrothermal process, which generally involves special equipment and heat treatment, and requires additional stabilizers to make it solution-processable. In this work, we report a facile one-step approach to synthesize water-dispersible sulfur-doped reduced graphene oxide (S-rGO). Graphene oxide (GO) could be readily reduced and converted to S-rGO simultaneously by directly mixing GO dispersion with hydrosulfide hydrate (NaSH·xH2O) at room temperature. The sulfur doping is confirmed by high resolution S 2p XPS spectrum and element mapping. The colloidal dispersion state of S-rGO is confirmed by the investigation of Tyndall effect, the zeta potential and particle size distribution measurement. Compared with previously reported strategies, NaSH can initiate the reduction and sulfur doping at room temperature, demand no heat treatment, require no equipment and form stable aqueous S-rGO dispersion without using any stabilizer. These advantages will facilitate large-scale production of water-dispersible (sulfur doped) graphene and further boost their applications in sensors, catalysts and energy storage devices.

SELECTION OF CITATIONS
SEARCH DETAIL
...